Consent to Distribution of Medicines




10 MARCH 2005

NEW ZEALAND GAZETTE, No. 48

1259

Product:
NovoSeven
Active Ingredient:
Factor VIIa, recombinant human 4.8mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novo Nordisk Pharmaceuticals Limited
Manufacturer:
Novo Nordisk A/S, Gentofte, Denmark

Product:
Rapilysin
Active Ingredient:
Reteplase 10U
Dosage Form:
Powder for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturers:
Roche Diagnostics GmbH, Mannheim, Germany

Product:
Saizen 1.33
Active Ingredient:
Somatropin 1.33mg equivalent to 4IU
Dosage Form:
Powder for injection
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Industria Farmaceutica Serono SpA, di Modugno, Bari, Italy
Laboratoires Serono SA, l’Ouriettaz, Aubonne, Switzerland

Product:
Saizen 3.33
Active Ingredient:
Somatropin 3.33mg equivalent to 10IU Includes 0.33mg overfill
Dosage Form:
Powder for injection
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Laboratoires Serono SA, l’Ouriettaz, Aubonne, Switzerland

Product:
Saizen 8
Active Ingredient:
Somatropin 8mg equivalent to 24IU, plus 0.8mg overfill
Dosage Form:
Multidose vial powder for injection
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturers:
Industria Farmaceutica Serono SpA, di Modugno, Bari, Italy
Laboratoires Serono SA, l’Ouriettaz, Aubonne, Switzerland

Dated this 2nd day of March 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1325

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product:
Influvac
Active Ingredients:
Influenza virus A/Wellington/1/2004(H3N2)-like strain 15µg/dose
Influenza virus B/Shanghai/361/2002-like strain 15µg/dose
Influenza virus haemagglutin type A/New Caledonia/20/99 H1N1-like strain 15µg/dose
Dosage Form:
Suspension for injection
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited
Manufacturer:
Solvay Pharmaceuticals BV, Olst, The Netherlands

Dated this 7th day of March 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1422

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Nodia
Active Ingredient:
Loperamide hydrochloride 2mg
Dosage Form:
Tablet
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Cipla Limited, Patalganga, District Raigad, (Maharashtra), India

Product:
Ovidrel
Active Ingredient:
Choriogonadotropin alfa 250µg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Industria Farmaceutica Serono SpA, di Modugno, Bari, Italy



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 48


Gazette.govt.nz PDF NZ Gazette 2005, No 48





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines (continued from previous page)

🏥 Health & Social Welfare
2 March 2005
Medicines, Distribution, NovoSeven, Rapilysin, Saizen 1.33, Saizen 3.33, Saizen 8, Factor VIIa, Reteplase, Somatropin
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
7 March 2005
Medicines, Distribution, Influvac, Influenza vaccine
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
7 March 2005
Medicines, Distribution, Nodia, Ovidrel, Loperamide hydrochloride, Choriogonadotropin alfa
  • DON MATHESON, Deputy Director-General, Public Health